{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-014850","form_type":"8-K","ticker":"IKT","cik":"0001750149","company_name":"Inhibikase Therapeutics, Inc.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.404068+00:00","generated_at":"2026-06-20T09:36:10.435291+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"FDA lifts full clinical hold on Inhibikase's IkT-148009 for Parkinson's; Phase 2a trial restarting","bullets":["FDA lifted full clinical hold on IkT-148009; Phase 2a 201 trial resumes at 50 and 100 mg doses.","Company will measure safety and steady-state PK of 200 mg in 6 healthy subjects before PD patient dosing.","Expanded ocular monitoring includes cornea/lens; no ocular pathology observed to date.","Inhibikase intends to seek lift of clinical hold on its Multiple System Atrophy (MSA) program.","Publication in Science Translational Medicine shows IkT-148009 halts neurodegeneration and reduces alpha-synuclein pathology in mouse models."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-014850","json":"https://secwatch.observer/filing/0001193125-23-014850.json","markdown":"https://secwatch.observer/filing/0001193125-23-014850.md","text":"https://secwatch.observer/filing/0001193125-23-014850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750149/000119312523014850/0001193125-23-014850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750149/000119312523014850/d439029d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:36:10.435291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}